We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Oxford Biomedica | AQSE:OXB.GB | Aquis Stock Exchange | Ordinary Share | GB00BDFBVT43 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
5.00 | 2.60% | 197.50 | 190.00 | 205.00 | 197.50 | 192.50 | 192.50 | 0.00 | 14:26:47 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMOXB
RNS Number : 9526Q
Oxford Biomedica PLC
05 December 2016
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons
1 Issuer Oxford BioMedica PLC ------ ------------------------ ---------------------------------- 2 Reason for notification Notification relates to DTR 3.1.2R ------ ------------------------ ---------------------------------- 3 Name of PDMR Martin Diggle ------ ------------------------ ---------------------------------- 4 Connected person Notification relates to following connected persons: Vulpes Life Sciences Fund ------ ------------------------ ---------------------------------- 5 Notification Notification in respect of in respect of holdings of persons in 4 above ------ ------------------------ ---------------------------------- 6 Description Oxford BioMedica PLC ordinary of shares shares of 1p each ------ ------------------------ ---------------------------------- 7 Name of registered Vulpes Life Sciences Fund shareholders - 575,850,000 shares and number of shares ------ ------------------------ ---------------------------------- 8 Nature of transaction Acquisition ------ ------------------------ ---------------------------------- 9 Number of shares Vulpes Life Sciences Fund acquired - 4,082,333 shares ------ ------------------------ ---------------------------------- 10 Percentage of Vulpes Life Sciences Fund issued class - 0.13% acquired ------ ------------------------ ---------------------------------- 11 Shares disposed N/A ------ ------------------------ ---------------------------------- 12 Percentage of N/A issued class disposed ------ ------------------------ ---------------------------------- 13/14 Price per share Vulpes Life Sciences Fund of transactions, 4,082,333 shares @ GBP0.0357 and date , 02 Dec 2016 ------ ------------------------ ---------------------------------- 15 Total holding Vulpes Life Sciences Fund following notification - 546,599,000 shares and total percentage 17.70% holding following Vulpes Testudo Fund - 33,333,333 notification shares 1.08% ------ ------------------------ ---------------------------------- 16 Date issuer 05 Dec 2016 informed ------ ------------------------ ---------------------------------- 23 Any additional None information ------ ------------------------ ---------------------------------- 24 Contact name T. Watts, Chief Financial and telephone Officer number Oxford BioMedica +44 (0)1865 783000 ------ ------------------------ ----------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHGCBDDGSGBGLU
(END) Dow Jones Newswires
December 05, 2016 04:43 ET (09:43 GMT)
1 Year Oxford Biomedica Chart |
1 Month Oxford Biomedica Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions